Smith & Nephew (SNN) Cash & Equivalents Growth (1y) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Smith & Nephew | 5.16 Bn | 4.58 Bn | - | -10.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.02% |
| Jun 28, 2025 | 19.01% |
| Dec 31, 2024 | 104.97% |
| Dec 31, 2023 | -13.71% |
| Dec 31, 2022 | -85.45% |
| Dec 31, 2021 | 835.80% |
| Dec 31, 2020 | 0.00% |
| Dec 31, 2019 | -22.82% |
| Dec 31, 2018 | 114.84% |
| Dec 31, 2017 | 307.89% |
| Dec 31, 2016 | -62.75% |
| Dec 31, 2015 | 56.92% |
| Dec 31, 2014 | -61.08% |
| Sep 30, 2014 | -7.35% |
| Mar 31, 2014 | -15.20% |
| Dec 31, 2013 | 3.73% |
| Sep 28, 2013 | -69.44% |
| Jun 29, 2013 | -54.30% |
| Mar 31, 2013 | -50.79% |
| Dec 31, 2012 | -17.44% |
| Sep 29, 2012 | 128.21% |
| Jun 30, 2012 | 13.33% |
| Mar 31, 2012 | 18.14% |
| Dec 31, 2011 | 12.07% |
| Sep 30, 2011 | 12.07% |
| Jun 30, 2011 | 12.07% |
| Mar 31, 2011 | -55.02% |
| Dec 31, 2010 | 2,800.00% |
| Sep 30, 2010 | 42.62% |
| Jun 30, 2010 | 42.62% |
| Mar 31, 2010 | 141.41% |